SciClone Pharmaceuticals, Inc. Gets New Subpoena From SEC in FCPA Probe

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SciClone Pharmaceuticals Inc. said Friday it had received another subpoena from federal authorities in the course of a long-running foreign corruption probe. The Foster City, Calif.-drug company said in its quarterly report it received a subpoena from the Securities and Exchange Commission in the fourth quarter of 2012. The SEC and the Department of Justice have been investigating SciClone since 2010 for possible violations of the U.S. Foreign Corrupt Practices Act.

Help employers find you! Check out all the jobs and post your resume.

Back to news